Previous reports indicated that IFN-β-stimulated dendritic cells engage TRAIL to mediate tumour cell killing [36] and suggested TRAIL expression in peripheral blood mononuclear cells to be IFN-dependent [37]. The gene discussed is IFNB1; the disease is neoplasm.